#ITI#Interleukin-2 production in SC and TK chickens infected with Eimeria tenella#FTI#
#IRE#SC and TK inbred chicken strains display differential protective immunity to coccidiosis, SC being more resistant and TK susceptible to disease. In this study, the association between interleukin (IL)-2 and disease phenotype was assessed by cytokine quantification in serum, duodenum, cecum, and spleen cell cultures of SC and TK chickens experimentally infected with Eimeria tenella. In general, after primary infection, SC and TK strains produced equivalent amounts of IL-2 in all sources examined. However, after secondary infection, SC animals displayed significantly greater IL-2 levels in serum and the duodenum compared with strain TK. IL-2 production after reinfection with Eimeria may be an important factor contributing to the genetic differences in coccidiosis between SC and TK chickens and provides a rational foundation for cytokine-based immunotherapeutic approaches to disease control strategies.#FRE#
#IPC#Cell-mediated immunity; Coccidiosis; Cytokine; ELISA#FPC#
#IRF#Bessay M., Le Vern Y., Kerboeuf D., Yvore P., Quere P., Changes in intestinal intra-epithelial and systemic T-cell subpopulations after an Eimeria infection in chickens: Comparative study between E. acervulina and E. tenella, Vet. Res., 27, pp. 503-514, (1996); 
Choi K.D., Lillehoj H.S., Role of chicken IL-2 on γδ T-cells and Eimeria acervulina-induced changes in intestinal IL-2 mRNA expression and γδ T-cells, Vet. Immunol. Immunopathol., 73, pp. 309-321, (2000); 
Choi K.D., Lillehoj H.S., Song K.D., Han J.Y., Molecular and functional characterization of chicken IL-15, Dev. Comp. Immunol., 23, pp. 165-177, (1999); 
Choi K.D., Lillehoj H.S., Zalenga D.S., Changes in local IFN-γ and TGF-β 4 mRNA expression and intraepithelial lymphocytes following Eimeria acervulina infection, Vet. Immunol. Immunopathol., 71, pp. 263-275, (1999); 
Dillman R.O., The clinical experience with interleukin-2 in cancer therapy, Cancer Biother., 9, pp. 183-209, (1994); 
Farner N.L., Hank J.A., Sondel P.M., Interleukin-2: Molecular and clinical aspects, Cytokines in health and disease, pp. 29-40, (1997); 
Farrar W.L., Johnson M.H., Farrar J.J., Regulation of the production of immune interferon and cytotoxic T lymphocytes by IL-2, J. Immunol., 126, pp. 1120-1125, (1981); 
Flexner C., Huegin A., Moss B., Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression, Nature, 330, pp. 259-262, (1987); 
Gillis S., Ferm M., Ou W., Smith K.A., T cell growth factor: Parameters of production and a quantitative microassay for activity, J. Immunol., 120, pp. 2027-2032, (1978); 
Hazama M., Mayumi-Aono A., Askawa N., Kuroda S., Hinuma S., Fujisawa Y., Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2, Vaccine, 11, pp. 629-636, (1993); 
Isobe T., Lillehoj H.S., Dexamethasone suppresses T cell-mediated immunity and enhances disease susceptibility to Eimeria mivati infection, Vet. Immunol. Immunopathol., 39, pp. 431-446, (1993); 
Kaiser P., Mariani P., Promoter sequence, exon:intron structure, and synteny of genetic location show that a chicken cytokine with T-cell proliferative activity is IL-2 and not IL-15, Immunogenetics, 49, pp. 26-35, (1999); 
Lillehoj E.P., Yun H.C., Lillehoj H.S., Vaccines against the avian enteropathogens Eimeria, Cryptosporidium and Salmonella, Anim. Health Res. Rev., 1, pp. 47-65, (2000); 
Lillehoj H.S., Effects of immunosuppression on avian coccidiosis: Cyclosporin A but not hormonal bursectomy abrogates host protective immunity, Infect. Immun., 55, pp. 1616-1621, (1987); 
Lillehoj H.S., Analysis of Eimeria acervulina-induced changes in the intestinal T lymphocyte subpopulations in two chicken strains showing different levels of susceptibility to coccidiosis, Res. Vet. Sci., 56, pp. 1-7, (1994); 
Lillehoj H.S., Role of T lymphocytes and cytokines in coccidiosis, Int. J. Parasitol., 28, pp. 1071-1081, (1998); 
Lillehoj H.S., Bacon L.D., Increase of intestinal intraepithelial lymphocytes expressing CD8 antigen following challenge infection with Eimeria acervulina, Avian Dis., 35, pp. 294-301, (1991); 
Lillehoj H.S., Kaspers B., Jenkins M.C., Lillehoj E.P., Avian interferon and interleukin- 2. A review by comparison with mammalian homologues, Poult. Sci., 4, pp. 67-85, (1992); 
Martin A., Awadalla S., Lillehoj H.S., Characterization of cell-mediated responses to Eimeria acervulina antigens, Avian Dis., 39, pp. 538-547, (1995); 
Mittler R., Rao P., Olini G., Westberg E., Newman W., Hoffman M., Goldstein G., Activated human B cells display a functional IL-2 receptor, J. Immunol., 134, pp. 2393-2399, (1985); 
Miyamoto T., Lillehoj H.S., Sohn E.J., Min W., Production and characterization of monoclonal antibodies detecting chicken interleukin-2 and the development of an antigen capture enzyme-linked immunosorbent assay, Vet. Immunol. Immunopathol., 80, pp. 245-257, (2001); 
Myers T.J., Lillehoj H.S., Fetterer R.H., Partial purification and characterization of chicken interleukin-2, Vet. Immunol. Immunopathol., 34, pp. 97-114, (1992); 
Nakamura Y., Nishimura T., Tokuda Y., Kobayashi N., Watanabe K., Noto T., Mitomi T., Sagamura K., Haba S., Macrophage-T cell interaction is essential for the induction of p75 interleukins (IL-2) receptor and IL-2 responsiveness in human CD4<sup>+</sup> T cells, Jpn. J. Cancer Res., 82, pp. 257-261, (1991); 
Nakane P., Kawaoi A., Peroxidase-labeled antibody. A new method of conjugation, J. Histochem. Cytochem., 22, pp. 1084-1091, (1974); 
Nakao M., Hazama M., Muyami-Aono A., Hinuma S., Fujisawa Y., Immunotherapy of acute and recurrent herpes simplex virus type 2 infection with an adjuvant-free form of recombinant glycopro-tein D-interleukin-2 fusion protein, J. Infect. Dis., 169, pp. 787-791, (1994); 
Reddy P.G., Blecha F., Minocha H.C., Anderson G.A., Morrill J.L., Fedorka-Cray P.J., Baker P.E., Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infection, Vet. Immunol. Immunopathol., 23, pp. 61-74, (1989); 
Rosenberg S.A., Lotze M.T., Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes, Ann. Rev. Immunol., 4, pp. 681-709, (1986); 
Rothwell L., Gramzinski R.A., Rose M.E., Kaiser P., Avian coccidiosis: Changes in intestinal lymphocyte populations associated with the development of immunity to Eimeria maxima, Parasite Immunol., 17, pp. 525-533, (1995); 
Rubin J.T., Interleukin-2: Its rationale and role in the treatment of patients with cancer, Cancer Treat. Res., 80, pp. 83-105, (1995); 
Schauenstein K., Globerson A., Wick G., Avian lymphokines. 1. Thymic cell growth factor in supernatants of mitogen stimulated chicken spleen cells, Dev. Comp. Immunol., 6, pp. 533-540, (1982); 
Schmatz D.M., Crane M.J., Murray P.K., Purification of Eimeria sporozoites by DE-52 anion exchange chromatography, J. Protozool., 31, pp. 181-183, (1984); 
Schnetzler M., Oommen A., Nowak J.S., Franklin R.M., Characterization of chicken T cell growth factor, Eur. J. Immunol., 13, pp. 560-566, (1983); 
Sneller M.C., Consensus symposium on combined antiviral therapy: Overview of interferon and IL-2 combinations for the treatment of HIV infection, Antiviral Res., 29, pp. 105-109, (1996); 
Stepaniak J.A., Shuster J.E., Hu W., Sundick R.S., Production and in vitro characterization of recombinant chicken interleukin-2, J. Interferon Cytokine Res., 19, pp. 515-526, (1999); 
Sundick R.S., Gill-Dixon C., A cloned chicken lymphokine homologous to both mammalian IL-2 and IL-15, J. Immunol., 159, pp. 720-725, (1997); 
Trinchieri G., Matsumoto-Kobayashi M., Clark S.C., Response of resting human peripheral blood NK cells to IL-2, J. Exp. Med., 16, pp. 1147-1169, (1984); 
Whittington R., Faulds D., Interleukin-2: A review of its pharmacological properties and therapeutic use in patients with cancer, Drugs, 46, pp. 446-514, (1993); 
Yoshizaki K., Nakagawa T., Fukunaga K., Kaieda T., Maruyama S., Kishimoto S., Yamamura Y., Kishimota T., Characterization of human B cells growth factor (BCGF) from cloned T cells or mitogen stimulated T cells, J. Immunol., 130, pp. 1241-1246, (1983); 
Yun C.H., Lillehoj H.S., Choi K.D., Eimeria tenella infection induces local gamma interferon production and intestinal lymphocyte subpopulation changes, Infect. Immun., 68, pp. 1282-1288, (2000); 
Yun C.H., Lillehoj H.S., Zhu J., Min W.G., Kinetics differences in intestinal and systemic interferon-γ and antigen-specific antibodies in chickens infected with Eimeria maxima, Avian Dis., 44, pp. 305-312, (2000); 
Zhang S., Lillehoj H.S., Ruff M.D., Chicken tumor necrosis-like factor. I. In vitro production by macrophages stimulated with Eimeria tenella or bacterial lipopolysaccharide, Poult. Sci., 74, pp. 1304-1310, (1995); 
Zhang S., Lillehoj H.S., Ruff M.D., In vivo role of tumor necrosis-like factor in Eimeria tenella infection, Avian Dis., 39, pp. 859-866, (1995)#FRF#
